Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of quinidine drug resistance genes in Candida albicans

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Candida albicans

PROVIDER: GSE41535 | GEO | 2013/03/01

SECONDARY ACCESSION(S): PRJNA177374

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptional profiling of quinidine drug resistance genes in Candida albicans

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-03-01 | E-GEOD-41535 | biostudies-arrayexpress

Mistranslation accelerates the evolution of antifungal drug resistance in Candida albicans

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-07-18 | GSE60122 | GEO

Candida albicans Ppr1 ChIP chip and transcriptional profiling data

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-04-15 | GSE80343 | GEO

Transcriptional analyses of antifungal drug resistance in Candida albicans.

Project description:Oral infections with the pathogenic yeast Candida albicans are one of the most frequent and earliest opportunistic infections in human immunodeficiency virus-infected patients. The widespread use of azole antifungal drugs has led to the development of drug-resistant isolates. Several molecular mechanisms that contribute to drug resistance have been identified, including increased mRNA levels for two types of efflux pump genes: the ATP binding cassette transporter CDRs (CDR1 and CDR2) and the major facilitator MDR1. Using Northern blot analyses, the expression patterns of these genes have been determined during logarithmic and stationary phases of cell growth and during growth in different carbon sources in a set of matched susceptible and fluconazole-resistant isolates that have been characterized previously. MDR1, CDR1, and CDR2 are expressed early during logarithmic growth, CDR4 is expressed late during logarithmic growth, and CDR1 is preferentially expressed in stationary-phase cells. There is a small decrease in expression of these genes when the cells are grown in carbon sources other than glucose. While increased mRNA levels of efflux pump genes are commonly associated with azole resistance, the causes of increased mRNA levels have not yet been resolved. Southern blot analysis demonstrates that the increased mRNA levels in these isolates are not the result of gene amplification. Nuclear run-on assays show that MDR1 and CDR mRNAs are transcriptionally overexpressed in the resistant isolate, suggesting that the antifungal drug resistance in this series is associated with the promoter and trans-acting factors of the CDR1, CDR2, and MDR1 genes.

| S-EPMC90061 | biostudies-literature

Candida albicans SREBP transcription regulators

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-11-05 | GSE118419 | GEO

Function and regulation of Cph2 in Candida albicans

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-08-10 | E-GEOD-71904 | biostudies-arrayexpress

Profiling of Rgt1-regulated gene transcripts in the fungal pathogen Candida albicans

Project description:This SuperSeries is composed of the SubSeries listed below.

2007-03-01 | GSE7046 | GEO

Population genomics of drug resistance in Candida albicans.

Project description:We followed adaptation in experimental microbial populations to inhibitory concentrations of an antimicrobial drug. The evolution of drug resistance was accompanied in all cases by changes in gene expression that persisted in the absence of the drug; the new patterns of gene expression were constitutive. The changes in gene expression occurred in four replicate populations of the pathogenic fungus Candida albicans during 330 generations of evolution in the presence of the antifungal drug fluconazole. Genome-wide expression profiling of over 5,000 ORFs identified 301 whose expression was significantly modulated. Cluster analysis identified three distinct patterns of gene expression underlying adaptation to the drug. One pattern was unique to one population and included up-regulation of the multidrug ATP-binding cassette transporter gene, CDR2. A second pattern occurred at a late stage of adaptation in three populations; for two of these populations profiled earlier in their evolution, a different pattern was observed at an early stage of adaptation. The succession of early- and late-stage patterns of gene expression, both of which include up-regulation of the multidrug major facilitator transporter gene, MDR1, must represent a common program of adaptation to this antifungal drug. The three patterns of gene expression were also identified in fluconazole-resistant clinical isolates, providing further evidence that these patterns represent common programs of adaptation to fluconazole.

| S-EPMC123132 | biostudies-literature

Function and regulation of Cph2 in Candida albicans

Project description:This SuperSeries is composed of the SubSeries listed below.

2015-08-10 | GSE71904 | GEO

Anti-BRAF mutation drug resistance enhances EGFR expression in melanomas

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-12-17 | E-GEOD-45649 | biostudies-arrayexpress